Drugs / NaCl
last change Dec 2010 re-read 2 minutes ago

NaCl

Developed for
infectious disease with sepsis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00464204 Comparator Jul 2007 → May 2010 infectious disease with sepsis Fresenius Kabi Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NaCl ClinicalTrials.gov intervention name — accepted as the source's own label NCT00464204
Route Intravenous “NaCl 0.9 % was administered intravenously.” NCT00464204